1.Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V, et al. The long-term mortality and morbidity of behcet syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003. 82:60–76.
2.Kocer N., Islak C., Siva A., Saip S., Akman C., Kantarci O, et al. CNS involvement in neuro-behcet syndrome: An MR study. AJNR Am J Neuroradiol. 1999. 20:1015–1024.
3.Lee SH., Yoon PH., Park SJ., Kim DI. MRI findings in neuro-behcet's disease. Clin Radiol. 2001. 56:485–494.
4.Yesilot N., Mutlu M., Gungor O., Baykal B., Serdaroglu P., Akman-Demir G. Clinical characteristics and course of spinal cord involvement in behcet's disease. Eur J Neurol. 2007. 14:729–737.
5.Fukae J., Noda K., Fujishima K., Takahashi T., Hattori N., Okuma Y. Subacute longitudinal myelitis associated with behcet's disease. Intern Med. 2010. 49:343–347.
Article
6.Al-Araji A., Kidd DP. Neuro-behcet's disease: Epidemiology, clinical characteristics, and management. Lancet Neurol. 2009. 8:192–204.
7.Trebst C., Raab P., Voss EV., Rommer P., Abu-Mugheisib M., Zettl UK, et al. Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica. Nat Rev Neurol. 2011. 7:688–698.
Article
8.Uygunoglu U., Pasha M., Saip S., Siva A. Recurrent longitudinal extensive transverse myelitis in a neuro-behcet syndrome treated with infliximab. J Spinal Cord Med. 2015. 38:111–114.
9.Ditunno JF., Little JW., Tessler A., Burns AS. Spinal shock revisited: A four-phase model. Spinal Cord. 2004. 42:383–395.
Article